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Parathyroid hormone: an early 
predictor of symptomatic 
hypocalcemia after total 
thyroidectomy
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ABSTRACT
Objective: The purpose of this study was to evaluate if the measurement of peri-operative para-
thyroid hormone (PTH) is able to identify patients with increased risk of developing symptoms 
of hypocalcemia. Subjects and methods: Forty patients who underwent total thyroidectomy 
were studied prospectively. Ionized serum calcium and PTH were measured after induction of 
anesthesia, one hour (PTH1) and one day after surgery (PTH24). Patients were evaluated for 
symptoms of hypocalcemia and treated with calcium and vitamin D supplementation as ne-
cessary. Results: Symptomatic hypocalcemia developed in 16 patients. Symptomatic patients 
had significant lower PTH1 and greater drops in PTH levels. The selection of 12.1 ng/L as PTH1 
level cutoff level divided patients with and without symptoms with 93.7% sensitivity and 91.6% 
specificity. The selection of 73.5% as the cutoff value for PTH decrease resulted in 91.6% sen-
sitivity and 87.5% specificity. Conclusion: PTH1 levels and the drop in PTH levels are reliable 
predictors of developing symptomatic hypocalcemia after total thyroidectomy. Arq Bras Endocrinol 
Metab. 2012;56(3):168-72
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RESUMO
Objetivo: O objetivo deste estudo é avaliar se a medida perioperatória do hormônio da parati-
reoide (PTH) pode identificar os pacientes com maior risco de desenvolver sintomas de hipocal-
cemia. Sujeitos e métodos: Foram estudados quarenta pacientes submetidos à tireo diectomia 
total. A medida do cálcio sérico e do PTH foi feita após a indução anestésica, uma hora (PTH1) 
e um dia após a cirurgia. Os pacientes foram avaliados quanto à presença de sintomas de hipo-
calcemia e tratados com suplementação de cálcio e vitamina D quando necessário. Resultados: 
Dezesseis pacientes apresentaram sintomas de hipocalcemia. Os pacientes sintomáticos apre-
sentaram PTH1 significantemente menor e queda no PTH significativamente maior. Usando o 
valor de 12,1 ng/L como corte, conseguimos distinguir pacientes com e sem sintomas de hipo-
calcemia com sensibilidade de 93,7% e especificidade de 91,6%. Utilizando como corte a queda 
de 73,5% no valor do PTH, temos sensibilidade de 91,6% e especificidade de 87,5%. Conclusão: 
O PTH1 e a queda no PTH são bons preditores de hipocalcemia no pós-operatório de tireoidec-
tomia total Arq Bras Endocrinol Metab. 2012;56(3):168-72
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INTRODUCTION 
Thyroidectomy has been performed since 500 AD, and initially presented very high morbidity and 
mortality that persisted even to the time of Billroth, who 
in 1883 reported a 40% mortality rate in 20 thyroidec-
tomies. This high mortality possibly reflected a lack of 
knowledge concerning the parathyroid glands and their 
influence on calcium metabolism (1). By 1912, Theo-
dore Kocher recognized the need to preserve parathy-
roid glands, and had successfully performed more than 
5000, mostly subtotal thyroidectomies (1-3).
Hypocalcemia, usually transient, is the most com-
mon complication following total thyroidectomy, and 
occurs in 10% to 50% of cases. It is the result of para-
thyroid gland injury and can cause great discomfort to 
the patient (1,4-8).
Symptoms of serum hypocalcemia may not be ma-
nifest for up to four days after surgery and can signifi-
cantly lengthen hospital stay (4,9-11). Finding a sim-
ple and reliable method to predict which patients may 
show hypocalcemia could decrease patient discomfort, 
hospital stay and treatment costs associated with total 
thyroidectomy.
The purpose of this study is to evaluate if peri-ope-
rative measurement of parathyroid hormone (PTH) 
during total thyroidectomy may identify those patients 
with the greatest risk of developing symptoms of hypo-
calcemia.
SUBJECTS AND METHODS
We developed a prospective study in the São Paulo Hos-
pital of the Universidade Federal de São Paulo (Brazil) 
from January to August, 2006. Informed consent was 
obtained from all subjects, and the study was approved 
by the Research Ethics Committee of the Universidade 
Federal de São Paulo. The first author was present at all 
surgical procedures.
 Forty-four consecutive patients who underwent 
total thyroidectomy without simultaneous neck dissec-
tion were included. Four patients were eliminated: two 
had parathyroid adenomas identified during surgery, 
one because of problems in blood sample identifica-
tion, and one because the patient was unable to ade-
quately express herself. Therefore, information about 
forty patients was analyzed (37 females and 3 males). 
Ionized calcium and PTH levels were measured 
before the operation (induction of anesthesia – Ca0/
PTH0), one hour after the surgery (in the recovery 
room – Ca1/PTH1) and on the day following sur-
gery (Ca24/PTH24). Vitamin D levels were also de-
termined. Ionized calcium measurements were carried 
out in an AVL 9180 – Eletrolyte Analyzer, and PTH 
measurements in Roche Elecsys 1010, which provides 
results in approximately 10 minutes. The normal values 
for ionized calcium are 1.24-1.41 mmol/L and PTH 
15-65 ng/L. Vitamin D levels were determined by ra-
dioimmunoassay with Dia Sorin kit, and the measure-
ment was carried out using Wallac 1277 Gammamaster 
gamma counter. The normal levels for vitamin D are 
30-60 ng/mL.
Patients were monitored for postoperative symp-
toms of hypocalcemia: development of perioral or 
fingertip paresthesias or numbness, muscle cramping, 
tetany, or positive Chvostek’s or Trousseau’s sign. Pa-
tients were divided in two groups – those with and 
those without symptoms, and comparisons were made 
between the two groups. 
Symptomatic patients were treated with calcium 
and vitamin D supplementation and discharged when 
signs and symptoms were controlled. After discharge, 
patients were instructed to call the researchers if they 
developed any symptoms of hypocalcemia. All patients 
were evaluated in the 7th and 13th postoperative day, 
and then, every three months.
Statistical analyses were made with SPSS 13.0 for 
Windows, LEAD Technologies, Inc. The groups were 
compared using a Person’s X2 and Student’s t test. 
Diffe rences were considered significant when p < 0.05. 
RESULTS
Sixteen of forty (40%) total thyroidectomy patients 
developed symptoms of hypocalcemia. Thirty four pa-
tients were discharged on the first postoperative day, 
five on the second, and the patient who experienced the 
greatest drop in PTH levels (92%) and the lowest PTH 
concentration (5 ng/L) one hour after the surgery was 
hospitalized for five days.
All patients were discharged without symptoms or 
signs of hypocalcemia. Eight patients became symp-
tomatic on the first postoperative day, six on the se-
cond, and two only on the third postoperative day. Pa-
tients were followed up for at least 10 months (10-18 
months), and only one patient (2.5%) needed calcium 
supplementation six months after surgery. No patient 
needed to be readmitted to the hospital after discharge, 
and there were no surgical complications. 
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Mean age of symptomatic patients was 53.6 ± 16.5 
years, and for patients without symptoms 50.1 ± 14.7 
years (p = 0.48). Four parathyroid glands were identi-
fied in 19 patients, three in 16 patients, two parathyroid 
glands in three pacients, and only one parathyroid was 
identified in two patients. The number of parathyroid 
glands identified was not statistically different between 
symptomatic and asymptomatic patients (p = 0.46). 
Ten patients needed parathyroid transplantation (one 
parathyroid in nine patients, and two parathyroids in 
one patient). Among those patients who needed para-
thyroid transplantation, six (60%) became symptom-
atic, and in the group that did not need parathyroid 
transplantation, 10 patients (33%) became symptom-
atic. This difference, however, was not significant (p = 
0.136). Vitamin D levels were also similar in the symp-
tomatic and asymptomatic groups (21.6 ± 8.2 ng/mL 
and 23.9 ± 7.4 ng/mL, p = 0.88). Six patients showed 
hyperthyroidism in the preoperative period, and two 
(33%) of them developed symptoms of hypocalcemia.
In the group that did not develop symptoms, mean 
values were: 56.6 ± 24.4 ng/L for PTH0, 27.7 ± 14.5 
ng/L for PTH1, 26.8 ± 11.4 ng/L for PTH24, 1.23 ± 
0.7 mmol/L for Ca0, 1.21 ± 0.7 mmol/L for Ca1, and 
1.15 ± 0.6 mmol/L for Ca24. In those who develo-
ped symptoms, mean values were: 56.1 ± 18.5 ng/L 
for PTH0, 9.5 ± 6.5 ng/L for PTH1, 8.0 ± 3.4 ng/L 
for PTH24, 1.21 ± 0.5 mmol/L for Ca0, 1.17 ± 0.5 
mmol/L for Ca1 and 1.05 ± 0.5 mmol/L for Ca24. 
Ca0, PTH0 and Ca1 were similar between symptoma-
tic and asymptomatic groups (p = 0.47, p = 0.94, and p 
= 0.07 respectively). Patients in the symptomatic group 
had PTH1 significantly lower than patients in the 
asymptomatic group (p < 0.001) (Figure 1). PTH24 
and Ca24 were also statistically different between 
symptomatic and asymptomatic patients (p < 0.001). 
Thirty eight patients (95%) had ionized calcium levels 
below normal range in the first postoperative day, and 
the other two had ionized calcium levels in the lower 
limit of the reference range (1.24 mmol/L). 
PTH drop (difference between PTH1 and PTH0) 
was greater in the symptomatic group (82.2 ± 8.8% vs. 
47.4 ± 6.4%, p < 0.001) compared to the group of pa-
tients without symptoms (Figure 2).
PTH1 value below 12.1 ng/L predicted which pa-
tient had a greater chance of developing symptoms of 
hypocalcemia with 93.7% sensitivity and 91.6% specifici-
ty. PTH drop of 73.5% also effectively predicted symp-
toms of hypocalcemia among patients who underwent 
total thyroidectomy with 91.6% sensitivity and 87.5% 
specificity. The Roc curves show that both PTH1 value 
and PTH drop are reliable predictors of symptoms of 
hypocalcemia. Using 12.1 ng/L as PTH1 cutoff value, 
the area under the curve is 0.927 (Figure 3), and using 
73.5% as PTH drop cutoff value, the area under the 
curve is 0.896 (Figure 4).
0.0: patients without symptoms; 1.00: patients with symptoms.
Figure 1. PTH 1 hour after the surgery. 
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Figure 2. PTH drop (difference between PTH at induction and PTH one 
hour after surgery).
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determinations to try to predict which patients will de-
velop hypocalcemia. Neither strategy seems to be cost-
-effective, the former because all patients are exposed 
to side effects of calcium but less than half actually need 
the supplementation, and the latter because it can delay 
discharge and subject the patient to the discomfort of 
multiple venipuntures. Some protocols based on cal-
cium slope are useful (12-14), but still require serial 
measurements, postpone treatment and may prolong 
hospital stay. It is still difficult to predict whether a pa-
tient has a greater risk of developing hypocalcemia ba-
sed only on calcium levels or surgical events (15,16).
The success of rapid PTH determinations in para-
thyroid surgery led some investigators to evaluate its 
usefulness to predict hypocalcemia following thyroid 
surgery. Lam and Kerr found that all patients with 
PTH value less than 8 pg/mL measured one hour after 
the surgery became hypocalcemic, and all patients with 
PTH level greater than 9 pg/mL did not (17). Higgins 
and cols. demonstrated that 64% of those patients who 
subsequently required calcium supplementation had a 
decrease in PTH levels greater than 75% from baseline 
20 minutes after surgery, and 74% of those who did not 
need calcium supplementation demonstrated a decrea-
se of less than 75% from baseline (18). For Lombardi 
and cols., PTH less than 10 pg/mL measured four or 
six hours after surgery predicted hypocalcemia with an 
overall accuracy of 98% (19). Pattou and cols. repor-
ted that a postoperative PTH level of 12 pg/mL or 
less was a good predictor of hypocalcemia, but did not 
state how long after surgery PTH values were obtained 
(20). A group of Australian surgeons found that nor-
mal postoperative PTH levels accurately predicted nor-
mocalcemia after total thyroidectomy, and the optimal 
time to make the measurement was four hours after the 
surgery (21).
Almost all studies define hypocalcemia as either low 
serum calcium or development of symptoms of hypo-
calcemia (9,11,15-19,21-26). We used only the symp-
toms of hypocalcemia because we believe that mixing 
two parameters (biochemical hypocalcemia and symp-
tomatic hypocalcemia) can introduce a bias. Postopera-
tive serum calcium level can take up to four days to rea-
ch its lowest value (20) and, like Richards and cols., we 
also found that almost all patients have calcium levels 
below reference range after total thyroidectomy (27). 
Furthermore, the speed of decrease in calcium levels 
appears to be more important that the absolute value 
itself (4,20).
Figure 4. Roc curve with cutoff value of 73.5% for PTH drop.
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Figure 3. Roc curve with TH1 cutoff value of 12.1 ng/L. 
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DISCUSSION
Hypocalcemia is the most frequent complication of 
total thyroidectomy. Some physicians prescribe supple-
mentation of calcium and vitamin D to all total thyroi-
dectomy patients, while others obtain serial calcium 
PTH: predictor of symptomatic hypocalcemia
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Similar to other studies, we did not find a rela-
tionship between patient demographic characteristics 
and development of hypocalcemia (15,18-20,27-29), 
and although several authors have reported a rela-
tionship between hyperthyroidism and hypocalemia 
(1,7,28), our study (like those of Lombardi and cols. 
(29), Higgins and cols. (18) and Scurry and cols. (15) 
did not observe this relationship. Additionally, we 
found no relationship with the number of parathyroid 
glands identified or transplanted, which is in agreement 
with other authors (18,19,30).
CONCLUSION
Serum PTH determinations one hour after total thyroi-
dectomy and the decrease in PTH levels from the pre-
operative baseline are safe and reliable predictors of 
symptomatic hypocalcemia. A single measurement one 
hour after surgery is slightly more accurate and more 
cost-effective, since only one measurement is required.
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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